⌘K

Login Start Free

Home/Filings/4/0001213900-21-066820

4//SEC Filing

Ence Chuck 4

Accession 0001213900-21-066820

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 9:30 PM ET

Size

5.3 KB

Accession

0001213900-21-066820

Insider Transaction Report

Form 4

Period: 2021-12-17

RELMADA THERAPEUTICS, INC.RLMD

CAO and COO

Transactions

Award
Stock Option (right to buy)
2021-12-17+226,832→ 226,832 total
Exercise: $19.03From: 2022-03-17Exp: 2031-12-17→ Common Stock (226,832 underlying)

Footnotes (1)

[F1]The option vests in 16 equal quarterly installments commencing on March 17, 2022.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001697779

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 9:30 PM ET
Size: 5.3 KB

View on SEC.gov